Back to results
UnknownPhase 3

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

NCT03949634

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fudan University affiliated cancer hospital

Shanghai, China

Contact

jiandong nie, doctor

0311-66575708niejd@mail.ecspc.com
View on ClinicalTrials.gov
Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) — TrialFind